245 related articles for article (PubMed ID: 8692978)
1. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family.
Su ZZ; Lin J; Shen R; Fisher PE; Goldstein NI; Fisher PB
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7252-7. PubMed ID: 8692978
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of prostate carcinoma tumor antigen-1, PCTA-1, a human galectin-8 related gene.
Gopalkrishnan RV; Roberts T; Tuli S; Kang D; Christiansen KA; Fisher PB
Oncogene; 2000 Sep; 19(38):4405-16. PubMed ID: 10980616
[TBL] [Abstract][Full Text] [Related]
3. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display.
Shen R; Su ZZ; Olsson CA; Fisher PB
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6778-82. PubMed ID: 7542776
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
5. Expression of the prostate-specific membrane antigen.
Israeli RS; Powell CT; Corr JG; Fair WR; Heston WD
Cancer Res; 1994 Apr; 54(7):1807-11. PubMed ID: 7511053
[TBL] [Abstract][Full Text] [Related]
6. Serological cloning of PARIS-1: a new TBC domain-containing, immunogenic tumor antigen from a prostate cancer cell line.
Zhou Y; Toth M; Hamman MS; Monahan SJ; Lodge PA; Boynton AL; Salgaller ML
Biochem Biophys Res Commun; 2002 Jan; 290(2):830-8. PubMed ID: 11785977
[TBL] [Abstract][Full Text] [Related]
7. Novel human prostate-specific cDNA: molecular cloning, expression, and immunobiology of the recombinant protein.
Naz RK; Santhanam R; Tyagi N
Biochem Biophys Res Commun; 2002 Oct; 297(5):1075-84. PubMed ID: 12372395
[TBL] [Abstract][Full Text] [Related]
8. Surface-epitope masking: a strategy for the development of monoclonal antibodies specific for molecules expressed on the cell surface.
Shen R; Su ZZ; Olsson CA; Goldstein NI; Fisher PB
J Natl Cancer Inst; 1994 Jan; 86(2):91-8. PubMed ID: 7505832
[TBL] [Abstract][Full Text] [Related]
9. Galectin-8. A new rat lectin, related to galectin-4.
Hadari YR; Paz K; Dekel R; Mestrovic T; Accili D; Zick Y
J Biol Chem; 1995 Feb; 270(7):3447-53. PubMed ID: 7852431
[TBL] [Abstract][Full Text] [Related]
10. The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells.
Chen MW; Vacherot F; De La Taille A; Gil-Diez-De-Medina S; Shen R; Friedman RA; Burchardt M; Chopin DK; Buttyan R
Oncogene; 2002 Nov; 21(51):7861-71. PubMed ID: 12420223
[TBL] [Abstract][Full Text] [Related]
11. Amplification of immunoglobulin transcripts by the non-palindromic adaptor polymerase chain reaction (NPA-PCR). Nucleotide sequence analysis of two human monoclonal antibodies recognizing two cell surface antigens expressed in ovarian, cervix, breast, colon and other carcinomas.
Chen PF; Freedman RS; Chernajovsky Y; Platsoucas CD
Hum Antibodies Hybridomas; 1994; 5(3-4):131-42. PubMed ID: 7756578
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers.
An G; Ng AY; Meka CS; Luo G; Bright SP; Cazares L; Wright GL; Veltri RW
Cancer Res; 2000 Dec; 60(24):7014-20. PubMed ID: 11156405
[TBL] [Abstract][Full Text] [Related]
13. CTp11, a novel member of the family of human cancer/testis antigens.
Zendman AJ; Cornelissen IM; Weidle UH; Ruiter DJ; van Muijen GN
Cancer Res; 1999 Dec; 59(24):6223-9. PubMed ID: 10626816
[TBL] [Abstract][Full Text] [Related]
14. Surface-epitope masking (SEM): an immunological subtraction approach for developing monoclonal antibodies targeting surface-expressed molecules.
Goldstein NI; Fisher PB
Methods Mol Biol; 2007; 383():245-58. PubMed ID: 18217690
[TBL] [Abstract][Full Text] [Related]
15. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB
Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265
[TBL] [Abstract][Full Text] [Related]
16. Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples.
Sun Y; Lin J; Katz AE; Fisher PB
Cancer Res; 1997 Jan; 57(1):18-23. PubMed ID: 8988032
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype.
Ellerhorst J; Nguyen T; Cooper DN; Lotan D; Lotan R
Int J Oncol; 1999 Feb; 14(2):217-24. PubMed ID: 9917495
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line.
Chang K; Pastan I
Int J Cancer; 1994 Apr; 57(1):90-7. PubMed ID: 8150545
[TBL] [Abstract][Full Text] [Related]
19. D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancer.
Weigle B; Kiessling A; Ebner R; Fuessel S; Temme A; Meye A; Schmitz M; Rieger MA; Ockert D; Wirth MP; Rieber EP
Int J Cancer; 2004 May; 109(6):882-92. PubMed ID: 15027122
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis.
De Backer O; Arden KC; Boretti M; Vantomme V; De Smet C; Czekay S; Viars CS; De Plaen E; Brasseur F; Chomez P; Van den Eynde B; Boon T; van der Bruggen P
Cancer Res; 1999 Jul; 59(13):3157-65. PubMed ID: 10397259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
